Literature DB >> 7082905

Mechanisms of elevation of rat brain tryptophan concentration by various doses of salicylate.

A A Badawy.   

Abstract

1 The roles of inhibition of liver tryptophan pyrrolase activity and of displacement of tryptophan from its binding sites on serum proteins have been investigated in relation to the increase in rat brain tryptophan concentration after administration of various doses of sodium salicylate. 2 The elevation of brain tryptophan concentration by sodium salicylate (0.5 mg/kg) was caused by inhibition of liver pyrrolase activity, whereas that by doses of the drug of 50 mg/kg and above was achieved mainly by tryptophan displacement. Both tryptophan displacement of pyrrolase inhibition caused the increase in brain tryptophan concentration by sodium salicylate at 10 mg/kg. 3 The smallest dose of salicylate capable of displacing serum-protein-bound tryptophan was 2.5 mg/kg.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7082905      PMCID: PMC2068763          DOI: 10.1111/j.1476-5381.1982.tb09208.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  8 in total

1.  Effects of acetylsalicylic acid on serum protein binding and metabolism of tryptophan in man.

Authors:  H G Smith; C Lakatos
Journal:  J Pharm Pharmacol       Date:  1971-03       Impact factor: 3.765

2.  The effect of sodium salicylate on the binding of L-tryptophan to serum proteins.

Authors:  J N McArthur; P D Dawkins
Journal:  J Pharm Pharmacol       Date:  1969-11       Impact factor: 3.765

3.  Plasma tryptophan and 5-HT metabolism in the CNS of the newborn rat.

Authors:  S Bourgoin; A Faivre-Bauman; P Benda; J Glowinski; M Hamon
Journal:  J Neurochem       Date:  1974-08       Impact factor: 5.372

4.  Increase of brain tryptophan and stimulation of serotonin synthesis by salicylate.

Authors:  A Tagliamonte; G Biggio; L Vargiu; G L Gessa
Journal:  J Neurochem       Date:  1973-03       Impact factor: 5.372

5.  Changes in liver tryptophan and tryptophan pyrrolase activity after administration of salicylate and tryptophan to the rat.

Authors:  A A Badawy; M J Smith
Journal:  Biochem Pharmacol       Date:  1972-01       Impact factor: 5.858

6.  Inhibition of rat liver tryptophan pyrrolase activity and elevation of brain tryptophan concentration by administration of antidepressants.

Authors:  A A Badawy; M Evans
Journal:  Biochem Pharmacol       Date:  1981-06-01       Impact factor: 5.858

7.  Reversal by naloxone of the effects of chronic administration of drugs of dependence on rat liver and brain tryptophan metabolism.

Authors:  A A Badawy; M Evans; N F Punjani
Journal:  Br J Pharmacol       Date:  1981-10       Impact factor: 8.739

8.  The effects of salicylate on the activity of rat liver tryptophan pyrrolase in vitro and in vivo.

Authors:  A A Badawy; M J Smith
Journal:  Biochem J       Date:  1971-06       Impact factor: 3.857

  8 in total
  5 in total

1.  Proceedings of the British Pharmacological Society. 9th-11th September 1985. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1985-12       Impact factor: 8.739

2.  Alpha-adrenoceptor antagonism by apoyohimbine and some observations on the pharmacology of alpha-adrenoceptors in the rat anococcygeus and vas deferens.

Authors:  J C McGrath
Journal:  Br J Pharmacol       Date:  1984-08       Impact factor: 8.739

3.  Inhibition of rat liver tryptophan pyrrolase activity and elevation of brain tryptophan concentration by acute administration of small doses of antidepressants.

Authors:  A A Badawy; M Evans
Journal:  Br J Pharmacol       Date:  1982-09       Impact factor: 8.739

4.  Brain Versus Blood: A Systematic Review on the Concordance Between Peripheral and Central Kynurenine Pathway Measures in Psychiatric Disorders.

Authors:  Katrien Skorobogatov; Livia De Picker; Robert Verkerk; Violette Coppens; Marion Leboyer; Norbert Müller; Manuel Morrens
Journal:  Front Immunol       Date:  2021-09-23       Impact factor: 7.561

5.  Inflammation and serotonin deficiency in major depressive disorder: molecular docking of antidepressant and anti-inflammatory drugs to tryptophan and indoleamine 2,3-dioxygenases.

Authors:  Shazia Dawood; Samina Bano; Abdulla A-B Badawy
Journal:  Biosci Rep       Date:  2022-05-27       Impact factor: 3.976

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.